Test ID: CCOC Coccidioides Antibody, Complement Fixation and Immunodiffusion, Spinal Fluid
Reporting Name
Coccidioides Ab, CompF/ImmDiff, CSFUseful For
Diagnosing coccidioidomycosis using spinal fluid specimens
Specimen Type
CSFSpecimen Required
Container/Tube: Sterile vial
Specimen Volume: 2 mL
Collection Instructions: Submit specimen from collection vial 2 (preferred), 3, or 4.
Specimen Minimum Volume
1.2 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
CSF | Refrigerated (preferred) | 14 days | |
Frozen | 14 days |
Reference Values
Complement Fixation: Negative
If positive, results are titered.
Immunodiffusion: Negative
Results are reported as positive, negative, or equivocal.
Day(s) Performed
Monday through Friday
Test Classification
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
86635 x 3
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
CCOC | Coccidioides Ab, CompF/ImmDiff, CSF | 88745-5 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
81542 | Coccidioides Ab, CompF, CSF | 13917-0 |
21002 | Coccidioides, IgG, ImmDiff, CSF | 94662-4 |
21001 | Coccidioides, IgM, ImmDiff, CSF | 94663-2 |
Clinical Information
Coccidioidomycosis (valley fever, San Joaquin Valley fever) is a fungal infection found in the Southwestern US, Central America, and South America. It is acquired by inhalation of arthroconidia of Coccidioides immitis/posadasii. Usually, it is a mild, self-limiting pulmonary infection. Less commonly, chronic pneumonia may occur, progressing to fibronodular cavitary disease. A rash often develops within 1 to 2 days, followed by erythema nodosum or multiforme and accompanying arthralgias. About 2 weeks after exposure, symptomatic patients develop fever, cough, malaise, and anorexia; chest pain is often severe. Coccidioidomycosis may disseminate beyond the lungs to involve multiple organs, including the meninges.
IgG antibody is detected by the complement-fixation tests. Precipitating antibodies (IgM and IgG) are detected by immunodiffusion. They are rarely found in cerebrospinal fluid; however, their presence is associated with meningitis. Chronic coccidioidal pulmonary cavities are often accompanied by IgG and IgM precipitating antibodies.
Serologic testing for coccidioidomycosis should be considered when patients exhibit symptoms of meningeal infection and have lived in or traveled to areas where Coccidioides immitis/posadasii is endemic. Any history of exposure to the organism or travel cannot be overemphasized when coccidioidomycosis serologic tests are being considered.
Interpretation
Complement Fixation:
IgG antibody is detected by complement fixation (CF) testing. Any CF titer in cerebrospinal fluid (CSF) should be considered significant. A positive complement fixation test in unconcentrated CSF is diagnostic of meningitis.
Immunodiffusion:
IgM and IgG precipitins are rarely found in CSF. However, when present, they are diagnostic of meningitis (100% specific). Since the immunodiffusion test is 100% specific, it is helpful in interpreting CF results.
Clinical Reference
1. McHardy IH, Barker B, Thompson GR 3rd. Review of Clinical and Laboratory Diagnostics for Coccidioidomycosis. J Clin Microbiol. 2023;61(5):e0158122. doi:10.1128/jcm.01581-22
2. Ramanan P, Wengenack NL, Theel ES. Laboratory diagnosis for fungal infections. A review of current and future diagnostic assays. Clin Chest Med. 2017;38(3):535-554. doi:10.1016/j.ccm.2017.04.013
Report Available
3 to 6 daysMethod Name
Complement Fixation (CF)/Immunodiffusion (ID)
Forms
If not ordering electronically, complete, print, and send Infectious Disease Serology Test Request (T916) with the specimen.
Testing Algorithm
For more information see Meningitis/Encephalitis Panel Algorithm.
Special Instructions
mml-mbid-cnsinfections